U.S. Food and Drug Administration
Pediatric Dosage Guidelines Norvir™ (ritonavir) oral solution -- Table A
Updated December 18, 1997
Initiation and Adjustment of Dose to 400 mg Twice Daily (see Table II)
Body Surface Area
(m<) |
Twice Daily Dose
(250 mg/m<) |
Twice Daily Dose
(300 mg/m<) |
Twice Daily Dose
(350 mg/m<) |
Twice Daily Dose
(400 mg/m<) |
| 0.25 |
0.8 mL (62.mg) |
0.9 mL (75 mg) |
1.1 mL (87.5 mg) |
1.25 mL (100 mg) |
| 0.50 |
1.6 mL (125 mg) |
1.9 mL (150 mg) |
2.2 mL (175 mg) |
2.5 mL (200 mg) |
| 1.00 |
3.1 mL (250 mg) |
3.75 mL (300 mg) |
4.4 mL (350 mg) |
5 mL (400 mg) |
| 1.25 |
3.9 mL (312.5 mg) |
4.7 mL (375 mg) |
5.5 mL (437.5 mg) |
6.25 mL (500 mg) |
| 1.50 |
4.7 mL (375 mg) |
5.6 mL (450 mg) |
6.6 mL (525 mg) |
7.5 mL (600 mg) |
Back | Next
Table of Contents
This article was provided by
U.S. Food and Drug Administration.
It is a part of the publication Protease Inhibitors Backgrounder.
E-Mail
Printable Single-Page
Glossary
Share
